These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15720419)

  • 41. Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
    Lee KW; Yi J; Choi IS; Kim JH; Bang SM; Kim DW; Im SA; Kim TY; Yoon SS; Lee JS; Bang YJ; Park S; Kim BK; Cho HI; Heo DS
    Ann Hematol; 2009 Sep; 88(9):829-38. PubMed ID: 19172274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma.
    Troch M; Wöhrer S; Raderer M
    Anticancer Res; 2010 Feb; 30(2):635-9. PubMed ID: 20332482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
    Sup SJ; Alemañy CA; Pohlman B; Elson P; Malhi S; Thakkar S; Steinle R; Hsi ED
    J Clin Oncol; 2005 Jun; 23(16):3773-9. PubMed ID: 15809450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B-cell lymphoma and its subtypes.
    Watanuki-Miyauchi R; Kojima Y; Tsurumi H; Hara T; Goto N; Kasahara S; Saio M; Moriwaki H; Takami T
    Pathol Int; 2005 Jun; 55(6):324-30. PubMed ID: 15943789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
    Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
    J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.
    Linderoth J; Ehinger M; Akerman M; Cavallin-Ståhl E; Enblad G; Erlanson M; Jerkeman M
    Eur J Haematol; 2007 Aug; 79(2):146-9. PubMed ID: 17635238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy.
    Veelken H; Vik Dannheim S; Schulte Moenting J; Martens UM; Finke J; Schmitt-Graeff A
    Ann Oncol; 2007 May; 18(5):931-9. PubMed ID: 17395602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma.
    Barrans SL; Carter I; Owen RG; Davies FE; Patmore RD; Haynes AP; Morgan GJ; Jack AS
    Blood; 2002 Feb; 99(4):1136-43. PubMed ID: 11830458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group.
    Yamauchi A; Fujita S; Ikeda J; Nakamichi I; Fukuhara S; Hino M; Kanakura Y; Ogawa H; Sugiyama H; Kanamaru A; Aozasa K
    Am J Hematol; 2007 Oct; 82(10):893-7. PubMed ID: 17573693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
    J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic impact of diffuse large B-cell lymphoma subgroups in patients undergoing autologous SCT.
    Hallack Neto AE; Dulley FL; Coelho Siqueira SA; Pracchia LF; Belesso M; Saboya R; Sturaro D; Amigo-Filho JU; Mendrone Junior A; Chamone DA; Pereira J
    Bone Marrow Transplant; 2009 Feb; 43(4):323-5. PubMed ID: 18850022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma.
    Frost M; Newell J; Lones MA; Tripp SR; Cairo MS; Perkins SL
    Am J Clin Pathol; 2004 Mar; 121(3):384-92. PubMed ID: 15023043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.
    Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Prat J; Sierra J
    Ann Hematol; 2006 Sep; 85(9):597-603. PubMed ID: 16830142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas.
    Sonnen R; Schmidt WP; Müller-Hermelink HK; Schmitz N
    Br J Haematol; 2005 May; 129(3):366-72. PubMed ID: 15842660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma.
    Adams H; Tzankov A; Lugli A; Zlobec I
    J Clin Pathol; 2009 Nov; 62(11):986-97. PubMed ID: 18977805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.
    Ohshima K; Kawasaki C; Muta H; Muta K; Deyev V; Haraoka S; Suzumiya J; Podack ER; Kikuchi M
    Histopathology; 2001 Aug; 39(2):156-62. PubMed ID: 11493332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of prognostic factors in patients with diffuse large B-cell lymphoma.
    Peng F; Guo L; Yao WK; Zheng Y; Liu Y; Duan XM; Wang YP
    Indian J Pathol Microbiol; 2017; 60(1):87-91. PubMed ID: 28195099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful.
    Martin-Arruti M; Vaquero M; Díaz de Otazu R; Zabalza I; Ballesteros J; Roncador G; García-Orad A
    Histopathology; 2012 Apr; 60(5):785-92. PubMed ID: 22321048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The clinical characteristics and prognostic analysis of 147 cases of diffuse large B-cell lymphoma].
    Zhao Q; Fu WJ; Zhang CY; Du J; Xi H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):737-40. PubMed ID: 24103868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of immunohistochemical classification of diffuse large B-cell lymphoma.
    Alacacioglu I; Ozcan MA; Ozkal S; Piskin O; Turgut N; Demirkan F; Ozsan GH; Kargi A; Undar B
    Hematology; 2009 Apr; 14(2):84-9. PubMed ID: 19298719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.